The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Open accessAbstract
BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) has emerged as a global epidemic, with ~425,000 new cases estimated to occur annually. The global human immunodeficiency virus (HIV) infection epidemic has caused explosive increases in TB incidence and may be contributing to increases in MDR-TB prevalence. METHODS: We reviewed published studies and available surveillance data evaluating links between HIV infection and MDR-TB to quantify convergence of these 2 epidemics, evaluate the consequences, and determine essential steps to address these epidemics. RESULTS: Institutional outbreaks of MDR-TB have primarily affected HIV-infected persons. Delayed diagnosis, inadequate initial treatment, and prolonged infectiousness led to extraordinary attack rates and case-fatality rates among HIV-infected persons. Whether this sequence occurs in communities is less clear. MDR-TB appears not to cause infection or disease more readily than drug-susceptible TB in HIV-infected persons. HIV infection may lead to malabsorption of anti-TB drugs and acquired rifamycin resistance. HIV-infected patients with MDR-TB have unacceptably high mortality; both antiretroviral and antimycobacterial treatment are necessary. Simultaneous treatment requires 6-10 different drugs. In HIV-prevalent countries, TB programs struggle with increased caseloads, which increase the risk of acquired MDR-TB. Surveillance data suggest that HIV infection and MDR-TB may converge in several countries. CONCLUSIONS: Institutional outbreaks, overwhelmed public health programs, and complex clinical management issues may contribute to the convergence of the MDR-TB and HIV infection epidemics. To forestall disastrous consequences, infection control, rapid case detection, effective treatment, and expanded program capacity are needed urgently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Self-citationEdlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861
Self-citationGlobal Surveillance for Antituberculosis-Drug Resistance, 1994–1997
Pablos-Méndez, A., Raviglione, M. C., Laszlo, A., Binkin, N., Rieder, H. L., Bustreo, F., Cohn, D. L., Lambregts-van Weezenbeek, C. S. B., Kim, S. J., Chaulet, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382301 · Cited by 815
Accelerated course of human immunodeficiency virus infection after tuberculosis.
Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., & Ellner, J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812542 · Cited by 535
Global Incidence of Multidrug‐Resistant Tuberculosis
Zignol, M., Hosseini, M. S., Wright, A., Weezenbeek, C. L., Nunn, P., Watt, C. J., Williams, B. G., & Dye, C. (2006) · The Journal of Infectious Diseases · doi:10.1086/505877 · Cited by 524
Small, P. M., Shafer, R. W., Hopewell, P. C., Singh, S. P., Murphy, M. J., Desmond, E., Sierra, M. F., & Schoolnik, G. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281601 · Cited by 512
Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Global overview of injecting drug use and HIV infection among injecting drug users
Aceijas, C., Stimson, G. V., Hickman, M., & Rhodes, T. (2004) · AIDS · doi:10.1097/00002030-200411190-00010 · Cited by 444
International standards of tuberculosis care.
Mohan, A. (2006) · PubMed · Cited by 432
Multidrug-resistant Tuberculosis
Dooley, S. W., Jarvis, W. R., Marione, W. J., & Snider, D. E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-257 · Cited by 376
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
Burman, W. J., Gallicano, K., & Peloquin, C. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140050-00002 · Cited by 337
Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis
Chan, E. D., Laurel, V., Strand, M. J., Chan, J. F., Huynh, M.-L. N., Goble, M., & Iseman, M. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1159oc · Cited by 336
International Standards for Tuberculosis Care
Hopewell, P. C., Pai, M., Maher, D., Uplekar, M., & Raviglione, M. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70628-4 · Cited by 336
Vernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.276.15.1229 · Cited by 295
Mitchison, D. A. (1998) · PubMed · Cited by 288
Leimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
Self-citationDrobniewski, F. (2005) · JAMA · doi:10.1001/jama.293.22.2726 · Cited by 235
Yew, W. W., Chan, C. K., Chau, C. H., Tam, C. M., Leung, C. C., Wong, P. C., & Lee, J. (2000) · Chest · doi:10.1378/chest.117.3.744 · Cited by 231
Interim policy on collaborative TB / HIV activities.
Getahun, H., van Gorkom, J., Harries, A. D., Harrington, M., & Nunn, P. (2004) · Cited by 227
Beijing/W Genotype Mycobacterium tuberculosis and Drug Resistance
Glynn, J. R., Kremer, K., Borgdorff, M. W., et al. (2006) · CINECA IRIS Institutial research information system (University of Pisa) · Cited by 217
Risk Factors for Tuberculosis in HIV-lnfected Persons: A Prospective Cohort Study
Antonucci, G. (1995) · JAMA · doi:10.1001/jama.1995.03530020061033 · Cited by 216
Beijing/W Genotype Mycobacterium tuberculosis and Drug Resistance
Tuberculosis, E. C. A. O. N. G. G. M. A. T. F. T. E. A. C. O. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1205.050400 · Cited by 212
Determinants of drug-resistant tuberculosis: analysis of 11 countries.
Espinal, M., Laserson, K., Camacho, M., Fusheng, Z., Kim, S. J., Tlali, R. E., Smith, I., Suarez, P. G., Antunes, M. L., George, A., et al. (2001) · PubMed · Cited by 203
Self-citationCoronado, V. G., Beck-Sague, C. M., Hutton, M. D., Davis, B. J., Nicholas, P., Villareal, C., Woodley, C. L., Kilburn, J. O., Crawford, J. T., Frieden, T. R., et al. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1052 · Cited by 200
The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis.
Blomberg, B., Spinaci, S., Fourie, B. P., & Laing, R. O. (2001) · Europe PMC (PubMed Central) · Cited by 176
Ritacco, V., Di Lonardo, M., Reniero, A., Ambroggi, M., Barrera, L., Dambrosi, A., Lopez, B., Isola, N., & de Kantor, I. N. (1997) · The Journal of Infectious Diseases · doi:10.1086/514084 · Cited by 163
Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.
Park, M. M., Davis, A. L., Schluger, N. W., Cohen, H., & Rom, W. N. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542137 · Cited by 161
Reid, A., Scano, F., Getahun, H., Williams, B., Dye, C., Nunn, P., De Cock, K. M., Hankins, C., Miller, B., Castro, K. G., et al. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70549-7 · Cited by 161
Self-citationMultidrug-Resistant Tuberculosis in the New York State Prison System, 1990-1991
Valway, S. E., Greifinger, R. B., Papania, M., Kilburn, J. O., Woodley, C., DiFerdinando, G. T., & Dooley, S. W. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.1.151 · Cited by 160
Low Antituberculosis Drug Concentrations in Patients with AIDS
Peloquin, C. A., Nitta, A. T., Burman, W. J., Brudney, K. F., Miranda-Massari, J. R., McGuinness, M. E., Berning, S. E., & Gerena, G. T. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000901 · Cited by 158
Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L., & York, D. F. (2000) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0231 · Cited by 139
Glynn, J. R., Kremer, K., Borgdorff, M. W., et al. (2006) · Cited by 138
Ruddy, M. (2005) · Thorax · doi:10.1136/thx.2004.026922 · Cited by 133
Cohen, T., Lipsitch, M., Walensky, R. P., & Murray, M. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600349103 · Cited by 126
Mycobacterium tuberculosisBeijing Genotype and Risk for Treatment Failure and Relapse, Vietnam
Lan, N. T. N., Lien, H. T. K., Tung, L. B., Borgdorff, M. W., Kremer, K., & van Soolingen, D. (2003) · Emerging infectious diseases · doi:10.3201/eid0912.030169 · Cited by 125
HIV/AIDS Epidemics in Vietnam: Evolution and Responses
Hiển, N. T., Long, N. T., & Huan, T. Q. (2004) · AIDS Education and Prevention · doi:10.1521/aeap.16.3.5.137.35527 · Cited by 125
Increasing transparency in partnerships for health – introducing the Green Light Committee
Gupta, R., Cegielski, J. P., Espinal, M., Henkens, M., Kim, J. Y., Weezenbeek, C. S. B. L.-V., Lee, J., Raviglione, M. C., Suarez, P. G., & Varaine, F. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00960.x · Cited by 117
Self-citationExpanding Tuberculosis Case Detection by Screening Household Contacts
Becerra, M. C., Pachao-Torreblanca, I. F., Bayona, J. N., Celi, R., Shin, S. S., Kim, J. Y., Farmer, P. E., & Murray, M. B. (2005) · Public Health Reports · doi:10.1177/003335490512000309 · Cited by 111
The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe
Kelly, J. A., & Amirkhanian, Y. A. (2003) · International Journal of STD & AIDS · doi:10.1258/095646203765371231 · Cited by 110
Drug resistance in tuberculosis in India.
Paramasivan, C. N., & Venkataraman, P. (2004) · PubMed · Cited by 107
Holtz, T. H., Lancaster, J., Laserson, K. F., Wells, C. D., Thorpe, L. E., & Weyer, K. (2006) · PubMed · Cited by 101
Self-citationThe impact of HIV/AIDS on the control of tuberculosis in India
Williams, B. G., Granich, R., Chauhan, L. S., Dharmshaktu, N. S., & Dye, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501615102 · Cited by 98
Schwoebel, V., Weezenbeek, C. S. B. L.-V., Moro, M. L., Drobniewski, F. A., Hoffner, S. E., Raviglione, M. C., & Rieder, H. L. (2000) · European Respiratory Journal · doi:10.1183/09031936.00.16236400 · Cited by 97
Moro, M. L., Gori, A., Errante, I., et al. (1998) · PubMed · Cited by 96
Risk Factors for Rifampin Mono-resistant Tuberculosis
Ridzon, R., Whitney, C. G., McKenna, M. T., Taylor, J. P., Ashkar, S. H., Nitta, A. T., Harvey, S. M., Valway, S. E., Woodley, C. L., Cooksey, R. C., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9712009 · Cited by 95
XDR tuberculosis: an indicator of public-health negligence
Rie, A. V., & Enarson, D. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69575-5 · Cited by 94
Tuberculosis in a prison population in Malawi
Nyangulu, D. S., Harries, A. D., Kang'ombe, C., Yadidi, A. E., Chokani, K., Cullinan, T., Maher, D., Nunn, P., & Salaniponi, F. M. L. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05023-x · Cited by 92
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
Shin, S., Pasechnikov, A., Gelmanova, I. Y., Gg, P., Strelis, A. K., Mishustin, S. P., Barnashov, A., Karpeichik, Y., Andreev, Y. G., Vt, G., et al. (2006) · PubMed · Cited by 91
Substandard tuberculosis drugs on the global market and their simple detection.
Laserson, K. F., As, K., Kenyon, T. A., Layloff, T. P., & Nj, B. (2001) · PubMed · Cited by 90
Self-citationBactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG
Murugasu-Oei, B. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.917 · Cited by 87
Seung, K. J., Gel'manova, I. E., Gg, P., Vt, G., Pavlova, V. E., Sirotkina, O. B., Yanova, G. V., & Strelis, A. K. (2004) · Clinical Infectious Diseases · doi:10.1086/425005 · Cited by 86
Aerts, A., Habouzit, M., Mschiladze, L., Malakmadze, N., Sadradze, N., Menteshashvili, O., Portaels, F., & Sudre, P. (2000) · PubMed · Cited by 85
Extensively Drug-Resistant Tuberculosis—United States, 1993–2006
Tanoue, L. T. (2008) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(08)70747-3 · Cited by 85
Kenyon, T. A., Mwasekaga, M., Huebner, R. E., Rumisha, D., BINKIN, N. J., & Maganu, E. T. (1999) · PubMed · Cited by 85
Cations in the didanosine tablet reduce ciprofloxacin bioavailability
Sahai, J. V., Gallicano, K., Oliveras, L., et al. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.24 · Cited by 80
Day, J., Charalambous, S., Fielding, K., Hayes, R., Churchyard, G., & Grant, A. D. (2006) · PubMed · Cited by 79
An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991–1993
Chum, H. J., OʼBrien, R. J., Chonde, T. M., Graf, P., & Rieder, H. L. (1996) · AIDS · doi:10.1097/00002030-199603000-00009 · Cited by 79
Nosocomial Transmission of Multidrug-Resistant Mycobacterium tuberculosis in Spain
Rullán, J. V., Herrera, D., Cano, R., Moreno, V., Godoy, P., Peiró, E. F., Castell, J., Ibañez, C., Ortega, A., Agudo, L. S., et al. (1996) · Emerging infectious diseases · doi:10.3201/eid0202.960208 · Cited by 79
Podlekareva, D. N., Mocroft, A., Dragsted, U. B., Ledergerber, B., Beniowski, M., Lazzarin, A., Weber, J. N., Clumeck, N., Vetter, N., Phillips, A. N., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/506366 · Cited by 79
Does Tuberculosis Increase HIV Load?
Day, J. H., Grant, A. D., Fielding, K., Morris, L., Moloi, V., Charalambous, S., Puren, A. J., Chaisson, R. E., Cock, K. M. D., Hayes, R., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/424851 · Cited by 77
Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
Churchyard, G., Corbett, E. L., Kleinschmidt, I., Mulder, D. W., & Cock, K. M. D. (2000) · PubMed · Cited by 69
Drug Interactions with Antiviral Drugs
Taburet, A., & Singlas, E. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00005 · Cited by 69
Aragón, L. M., Navarro, F., Heiser, V., Garrigó, M., Español, M., & Coll, P. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl058 · Cited by 66
Tuberculosis epidemiology in India: a review.
Chadha, V. K. (2005) · PubMed · Cited by 63
Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana
Mosimaneotsile, B., Talbot, E. A., Moeti, T. L., Hone, N. M., Moalosi, G., Moffat, H., Lee, E., & Kenyon, T. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14745-9 · Cited by 63
HIV and pulmonary tuberculosis
Sonnenberg, P., Glynn, J. R., Fielding, K., Murray, J., Godfrey‐Faussett, P., & Shearer, S. (2004) · AIDS · doi:10.1097/00002030-200403050-00010 · Cited by 63
Integration of Antiretroviral Treatment Within Antenatal Care in Gauteng Province, South Africa
van der Merwe, K., Chersich, M., Technau, K., Umurungi, Y., Conradie, F., & Coovadia, A. H. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000243099.72770.d2 · Cited by 62
Pereira, M., Tripathy, S. P., Inamdar, V., Ramesh, K., Bhavsar, M., Date, A., Iyyer, R., Acchammachary, A., Mehendale, S. M., & Risbud, A. (2005) · PubMed · Cited by 62
Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model
Harries, A. D., Gomani, P., Teck, R., Ascurra, O., Bakali, E., Zachariah, R., Libamba, E., Mwansambo, A., Salaniponi, F. M. L., & Mpazanje, R. (2004) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2004.05.002 · Cited by 60
Rifampin‐Monoresistant Tuberculosis in New York City, 1993–1994
Munsiff, S. S., Joseph, S., Ebrahimzadeh, A., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/516146 · Cited by 60
Tuberculosis drug development pipeline: progress and hope
Spigelman, M., & Gillespie, S. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68388-8 · Cited by 58
Cavalieri, S. J., Biehle, J. R., & Sanders, W. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1542 · Cited by 57
Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya.
Githui, W. A., Jordaan, A. M., Juma, E., Kinyanjui, P., Karimi, F. G., Kimwomi, J., Meme, H., Mumbi, P., Streicher, E. M., Warren, R. M., et al. (2004) · PubMed · Cited by 49
Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique.
Macarthur, A., Gloyd, S. S., Perdigão, P., Noya, A., Sacarlal, J., & Kreiss, J. K. (2001) · PubMed · Cited by 48
An examination of the Global Fund at 5 years
Feachem, R. G., & Sabot, O. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69163-0 · Cited by 45
Usefulness of a New Mycobacteriophage-Based Technique for Rapid Diagnosis of Pulmonary Tuberculosis
Alcaide, F., Galí, N., Domínguez, J., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.7.2867-2871.2003 · Cited by 43
Tuberculosis epidemiology in six provinces of Vietnam after the introduction of the DOTS strategy.
Huong, N. T., Duong, B. D., Co, N. V., Quy, H. T., Tung, L. B., Broekmans, J. F., Bosman, M., Verhage, C., Kalisvaart, N., Borgdorff, M. W., et al. (2006) · PubMed · Cited by 42
Epidemic of tuberculosis in the former Soviet Union: Social and biological reasons
Toungoussova, O. S., Bjune, G. A., & Caugant, D. A. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.04.001 · Cited by 40
Association between HIV-1 infection and miscarriage
D'Ubaldo, C., Pezzotti, P., Rezza, G., Branca, M., & Ippolito, G. (1998) · AIDS · doi:10.1097/00002030-199809000-00017 · Cited by 40
Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam.
Quy, H. T., Buu, T. N., Cobelens, F. G. J., Lan, N. T. N., Weezenbeek, C. S. B. L.-V., & Borgdorff, M. W. (2006) · PubMed · Cited by 39
Toungoussova, O. S., Mariandyshev, A., Bjune, G. A., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1284-z · Cited by 37
Multidrug-resistant tuberculosis at an HIV testing center in Haiti
Joseph, P., Sévère, P., Ferdinand, S., Goh, K. S., Sola, C., Haas, D. W., Johnson, W. D., Rastogi, N., Pape, J. W., & Fitzgerald, D. W. (2006) · AIDS · doi:10.1097/01.aids.0000206505.09159.9a · Cited by 35
Knupp, C. A., & Barbhaiya, R. H. (1997) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199701)18:1<65::aid-bdd13>3.0.co;2-r · Cited by 30
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.
Warndorff, D. K., Yates, M. D., Ngwira, B. M., Chagaluka, S., Jenkins, P., Drobniewski, F. A., Pönnighaus, J. M., Glynn, J. R., & Fine, P. E. M. (2000) · PubMed · Cited by 29
The Global TB Drug Facility: innovative global procurement.
Kumaresan, J., Smith, I., Arnold, V., & Evans, P. (2004) · PubMed · Cited by 29
Assessing the Magnitude of the HIV/AIDS Epidemic in Burma
Beyrer, C., Razak, M. H., Labrique, A. B., & Brookmeyer, R. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200303010-00011 · Cited by 28
Antituberculosis Drug Resistance in the South of Vietnam: Prevalence and Trends
Huong, N. T., Lan, N. T. N., Cobelens, F. G. J., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/507906 · Cited by 28
Implications of the growing HIV-1 epidemic for tuberculosis control in Russia
Kazionny, B., Wells, C. D., Kluge, H. H. P., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06574-6 · Cited by 24
Self-citationImpact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia.
Morozova, I., Riekstiņa, V., Stūre, G., et al. (2003) · PubMed · Cited by 23
PEPFAR and HIV prevention in Africa
Kamwi, R., Kenyon, T. A., & Newton, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68879-x · Cited by 21
Clinical mismanagement and other factors producing antituberculosis drug resistance
Pablos-Méndez, A., & Lessnau, K. (2000) · Resurgent and emerging infectious diseases · doi:10.1007/978-94-011-4084-3_5 · Cited by 15
Cited by
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Self-citationPoint-of-Care Diagnostics for Global Health
Yager, P., Domingo, G. J., & Gerdes, J. (2008) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.10.061807.160524 · Cited by 1,076
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P., & Bayona, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60410-2 · Cited by 1,018
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 751
Metadata
- Authors
- Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A., Castro, K. G., & Weyer, K.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07
- Volume
- 196
- Issue
- s1
- Pages
- S86-S107
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2124019099
- Cited by
- 483
- References
- 96
- FWCI
- 23.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.